Our Doctors

Dr. Rohit Malde

Consultant Clinical & Radiation Oncologist

Language:
English, Hindi,

Experience:
20+ Years

OPD Available

    Apex Hospitals Borivali

    10:00 AM – 12:00 PM (By Appointment)

    Monday to Saturday

Book an Appointment

Dr. Rohit Malde is a highly accomplished and internationally trained clinical and radiation oncologist with over two decades of extensive clinical experience. He built his foundational expertise at India's premier Tata Memorial Hospital, Mumbai, where he completed his MD in Radiation Oncology and further honed his advanced practice through nearly a decade in the United Kingdom, earning the prestigious Fellowship of the Royal College of Radiologists (FRCR, UK).  

Dr. Malde specializes in treating complex malignancies including breast, urological, lung, and gastrointestinal cancers utilizing state-of-the-art high-precision radiotherapy techniques such as Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT), and brachytherapy. Practicing across leading medical centers in Mumbai such as Nanavati Super Speciality Hospital, Apex Hospital Mulund, Sun Superspeciality Hospital, and Phoenix Hospital, Dr. Malde delivers evidence-based, compassionate, and world-class cancer care.  

Areas of specialization:

Specialized Services 

Dr. Rohit Malde provides advanced radiation oncology and precise oncological interventions:  

  • High-Precision Radiotherapy (IMRT & IGRT): Advanced Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy to deliver targeted radiation doses while sparing surrounding healthy tissues.  
  • Stereotactic Body Radiation Therapy (SBRT): High-dose, highly focused radiation therapy for localized tumors with sub-millimeter precision.  
  • Brachytherapy: High-dose-rate (HDR) brachytherapy boost applications for primary and localized malignancies.  
  • Comprehensive Multidisciplinary Cancer Management: Individualized treatment planning combining radiation, chemotherapy, and supportive survivorship protocols for solid tumors.  

Conditions Treated 

  • Solid Tumors & Malignancies: Breast cancer, lung cancer, colorectal cancer, upper GI and hepatobiliary cancers, and sarcomas.  
  • Urological & Gynecological Cancers: Uro-oncological malignancies (prostate, bladder, renal cancers) and gynecological cancers.  
  • Central Nervous System & Head/Neck Pathologies: Brain tumors, neuro-oncology conditions, head and neck cancers, lymphomas, and skin cancers.  
Education:
  • FRCR in Clinical Oncology – The Royal College of Radiologists, UK (2011)  
  • D.N.B. in Radiation Oncology – National Board of Examinations, New Delhi (2003)  
  • M.D. in Radiation Oncology – Tata Memorial Hospital, University of Mumbai (2003)  
  • M.B.B.S. – Terna Medical College, Navi Mumbai, University of Mumbai (2000)  
Publications, Fellowship & Training:
  • A comparison of conformal and intensity modulated treatment planning techniques for early prostate cancer. Journal of Medical Imaging and Radiation Oncology.Vaarkamp J, Malde R, Dixit S & Hamilton C. Journal of Medical Imaging and Radiation Oncology 2009 July; 53 (3):310-7.
  • Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy. Jalali R, Malde R, Bhutani R, Budrukkar A, Badwe R and Sarin R. Breast2008 Feb;17(1):64-70.
  • Management of Malignant Pericardial Effusion. Malde R. &Bahl A. Foundation Years Journal, 2008, Vol 2, issue 4:181-184.
  • Calvarialintraosseoushemangiomas mimicking metastasis from renal cell carcninoma. Malde R, Moss T, Whittlestone T, Bahl A. Advances in Urology, Vol. 2008, Article ID 176392.
  • Should early cancers of the oral tongue be kept under surveillance after wide excision alone ? A prospective study. Gupta T, Agarwal JP, Laskar SG, Malde R, Gupta S, Shrivastava S, Dinshaw K. Journal of Clinical Oncology, 2006 ASCO Annual Meetings Part 1. Vol 24, No. 18S (June 20 Supplement), 2006: 5541
  • Concomitant weekly tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast conservation therapy: A prospective study. Jalali R, Malde R, Sarin R, Budrukkar A, Badwe R. European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Abstract 401,112.
  • Vanishing bone disease involving the pelvis. Malde R, Agarwal H, GhoshSarbaniLaskar, DinshawKetayun A. Journal of Cancer Research and therapeutics 2005 1(4): 227-8
  • High dose rate brachytherapy boost for primary nasopharyngeal carcinoma: Preliminary results of an ongoing prospective study. Malde R, Agarwal JP, Laskar SG, Gupta T, Dinshaw K. Bull Cancer 2005; 92(7-8): 45-50.
  • Primary, multifocal extranodal lymphoma presenting with multiple cranial nerve palsies: an unusual presentation of an uncommon entity. Malde R, Laskar S, Mukaden M. Leuk Lymphoma. 2004 Feb: 45(2):389.
  • Gliosarcoma occurring 8 years after treatment for medulloblastoma. Malde R, Jalali R, Muzumdar D, Shet T, Kurkure P. Childs Nerv Syst. 2004 Apr. 20(4):243-6.
  • Radiation therapy following complete response after “ABVD” chemotherapy in Hodgkins disease: Is there a need – Results from a prospective trial from a single institution. Laskar S, Muckaden MA, Saikia TK, Pai SK,Malde R, Ingle P et al. Int J Cancer Aug 2002 Supp. 13, 131.
Mumbai's Strongest Healthcare Cluster.
Standing Tall for You.
Apex Group of Hospitals — Borivali, Kandivali and Mulund, united as one network for a healthier Maharashtra. Authentic, transparent healthcare, built around you and the people you love.